Recombinant Bovine LOX-1/OLR1 Protein，His

LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1) is a type of scavenger receptor that plays a crucial role in cellular uptake of oxidized low-density lipoproteins (oxLDL), thus contributing to atherogenesis and cardiovascular diseases. It is primarily expressed in endothelial cells, macrophages, and vascular smooth muscle cells, where it is implicated in inflammatory processes and endothelial dysfunction. The binding of oxLDL to LOX-1 triggers several intracellular signaling pathways that promote inflammation, oxidative stress, and apoptosis, which are fundamental in the development of atherosclerosis. 

OLR1, the gene encoding LOX-1, has emerged as a significant target for investigating potential therapeutic interventions in vascular diseases. Recombinant LOX-1 protein studies allow for the elucidation of its structure-function relationship, the elucidation of its ligand-binding properties, and the investigation of its signaling mechanisms. Furthermore, understanding LOX-1's interactions with various ligands can provide insights into the pathophysiological roles of this receptor in cardiovascular diseases. As such, research into LOX-1 and its recombinant forms is vital for developing strategies aimed at modulating its activity for therapeutic benefits, particularly in managing conditions associated with dyslipidemia and atherosclerosis. Additionally, recombinant LOX-1 proteins can serve as valuable tools in drug discovery and the development of diagnostic markers, underscoring their importance in cardiovascular research. Overall, the investigation of LOX-1/OLR1 recombinant proteins represents a critical avenue for enhancing our understanding of cardiovascular pathology and potential treatment modalities.